Vigilantes.

In 2018 the USPSTF doubled back from advising against PSA screening to instead advising “individualized decision-making” which we now know preceded a significantly increasing trend of PSA testing across all Blue Cross Blue Shield beneficiaries ages 40-89. | Leapman, JAMA Oncol 2021